GNH USA

Europe — EMA

Orfiril (Sodium Valproate)

GNH USA supplies Orfiril (Sodium Valproate), a carboxylate anticonvulsant for epilepsy, bipolar disorder and migraine prevention.

Sodium Valproate

Request sourcing

1
Pack/s

What is Sodium Valproate?

Sodium Valproate, the active ingredient in Orfiril, is a carboxylate anticonvulsant presented as a oral tablet for systemic use. It is used to treat seizure disorders and is prescribed for patients requiring long‑term seizure control.

GNH USA supplies Orfiril as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Sodium Valproate used for?

Orfiril is an anticonvulsant that acts on neuronal excitability in several seizure‑related conditions. - Epilepsy: helps achieve broader seizure control across multiple seizure types. - Bipolar disorder: stabilises mood and reduces the frequency of manic episodes. - Migraine prophylaxis: decreases the number of migraine attacks when used preventatively.

What are the side effects of Sodium Valproate?

Adverse reactions to Sodium Valproate may vary in frequency and severity.

Common Side Effects: - Nausea or stomach upset - Tremor or mild shakiness - Weight gain or increased appetite - Hair thinning or loss - Drowsiness or fatigue - Elevated liver enzymes

Serious or Rare Side Effects: - Severe liver injury or failure - Pancreatitis - Thrombocytopenia or low platelet count - Hyperammonemic encephalopathy - Severe skin reactions such as Stevens‑Johnson syndrome - Acute pancreatitis

What precautions apply to Sodium Valproate?

When prescribing Sodium Valproate, clinicians should consider several safety aspects. - Liver function monitoring: baseline and periodic tests are recommended, especially in children. - Blood count monitoring: watch for thrombocytopenia and anemia. - Pregnancy risk: avoid use in women of childbearing potential unless no safer alternative exists. - Drug interactions: review concomitant medications for potential PK/PD interactions. - Renal function: adjust if significant impairment is present. Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

What does Sodium Valproate interact with?

Sodium Valproate may interact with a range of medicines, requiring careful management.

Major Interactions (Avoid): - Carbamazepine: increased risk of hepatotoxicity. - Phenobarbital: reduced valproate plasma levels. - Topiramate: heightened risk of hyperammonemia.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR. - Lamotrigine: risk of severe skin reactions. - Oral contraceptives: reduced efficacy of hormonal contraception. - Phenytoin: altered valproate concentrations. - Acetaminophen: potential for increased liver enzyme elevations.

Frequently asked questions

What conditions is Orfiril used to treat?+
Orfiril contains sodium valproate, an anticonvulsant indicated for the management of epilepsy, bipolar disorder and migraine prophylaxis. It helps reduce seizure frequency, stabilise mood swings and lower the number of migraine attacks when prescribed by a qualified healthcare professional.
How does sodium valproate work in the body?+
Sodium valproate increases the activity of the inhibitory neurotransmitter GABA, blocks voltage‑gated sodium channels and modulates T‑type calcium currents. These actions collectively dampen neuronal hyper‑excitability, which is a key factor in seizures and related neurological disturbances.
What is the usual dose of Orfiril?+
The dose of Orfiril is individualized by the prescribing clinician based on the patient’s age, weight, clinical condition and response to therapy. Dosage adjustments are made during treatment to achieve optimal seizure control while minimising side effects.
Is Orfiril safe to use during pregnancy or while breastfeeding?+
Sodium valproate carries a known risk of birth defects and developmental disorders when used during pregnancy, so it is generally avoided in women of child‑bearing potential unless no safer alternative exists. Limited data are available for breastfeeding, and a risk‑benefit assessment should be performed by the prescriber.
How do I order Orfiril from GNH USA?+
To request Orfiril, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Orfiril compare with other anticonvulsants?+
Compared with other anticonvulsants such as carbamazepine or lamotrigine, sodium valproate offers broad‑spectrum seizure control and mood‑stabilising properties but has a higher risk of liver toxicity and teratogenicity. Choice of therapy depends on the specific seizure type, comorbidities and individual patient risk factors.
What are the storage requirements for Orfiril?+
Orfiril tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and direct sunlight. Keep the container tightly closed and out of reach of children.
How is Orfiril administered?+
Orfiril is supplied as oral tablets that are taken by mouth with or without food, as directed by the prescribing clinician. The tablets should be swallowed whole and not chewed or crushed unless specifically advised.
What are the most serious risks associated with Orfiril?+
Serious risks include severe liver injury, pancreatitis, hyperammonemic encephalopathy, thrombocytopenia and life‑threatening skin reactions such as Stevens‑Johnson syndrome. Patients should be monitored regularly for signs of these conditions, and therapy should be stopped immediately if they occur.
Who should not take Orfiril?+
Orfiril is contraindicated in individuals with known hypersensitivity to sodium valproate, those with severe liver disease, mitochondrial disorders such as POLG‑related disease, and pregnant women unless no alternative therapy is available. Clinicians must review each patient’s medical history before initiating treatment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Sodium Valproate
Route
Oral Use
Manufacturer
Desitin Arzneimittel Gmbh
Origin
EU

Related products

Absenor

Absenor

Sodium Valproate

Orion Corporation
EU
Absenor

Absenor

Sodium Valproate

Orion Corporation
EU
Absenor

Absenor

Sodium Valproate

Orion Corporation
EU
Absenor Depot

Absenor Depot

Sodium Valproate

Orion Corporation
EU